The Liposome Co. Inc. on Wednesday said underwriters for itsrecently completed stock offering have exercised their optionto buy a 525,000 share overallotment at $10.75 a share. Grossproceeds from the offering, counting the purchases byHambrecht & Quist Inc. and Oppenheimer & Co. Inc., total $43.3million. Liposome (NASDAQ:LIPO), based in Princeton, N.J., saida total of 4,025,000 shares were sold through the offering.

(c) 1997 American Health Consultants. All rights reserved.